Gene overexpressed in cancer
US9376475B2 · kind B2 · utility
0Cited by
3References
10Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Aug 31, 2010 |
| Grant date | Jun 28, 2016 |
| Priority date | — |
| Expiry date | May 19, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q2600/136
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
Disclosed are a protein encoded by a gene having a nucleotide sequence represented by any of SEQ ID NOs: 1 to 65 or a fragment thereof, an antibody recognizing the protein or antigen-binding fragment thereof, and a polynucleotide having a sequence comprising at least 12 consecutive nucleotides of a nucleotide sequence represented by any of SEQ ID NOs: 1 to 65 or a nucleotide sequence complementary thereto. The gene and the protein of the invention is useful for diagnosing and treating cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.